As castration therapy remains the most effective form of therapeutic intervention in HSPC [42], once the tumor reached 100–150 mm3, host animals were randomized and subjected to either castration or sham treatment to determine the biological impact of R273C-p53 and R273H-p53 expression in the context of tumor progression. The gene discussed is TP53; the disease is neoplasm.